Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00283348 · ClinicalTrials.gov registry record

New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy

A clinical trial of Chronic Rejection, sponsored by Virginia Commonwealth University.

Completed
Registry status
121
Enrollment target
1
Study location

NCT00283348: Completed study of Chronic Rejection, sponsored by Virginia Commonwealth University.

NCT00283348 is a study of Chronic Rejection that has completed, run by Virginia Commonwealth University. The registered enrollment target is 121 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00283348, a study of Chronic Rejection, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
121 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation and affects the function of the transplanted kidney. It is hoped that by studying blood, urine, and tissue samples of kidney transplant patients, new ways of diagnosing and treating CAN may be found.

Conditions Studied

Study Locations (1)

Virginia

  • VCU Health System - Richmond

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2006-01
Est. Completion 2008-12
Virginia Commonwealth University

558 total trials

What the finished NCT00283348 record still lists

NCT00283348 is an observational study that tracks outcomes without assigning an intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Chronic Rejection appearing as the primary indexed condition, and to 0 interventions.

NCT00283348 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT00283348 about?

NCT00283348 is a clinical study titled "New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy". The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation and affects the function of the transplanted kidney. It is hoped that by studying blood, urine, and ...

What is the current status of trial NCT00283348?

This trial is currently completed. The enrollment target is 121 participants. The study started on 2006-01. Estimated completion is 2008-12.

What conditions does trial NCT00283348 study?

This clinical trial studies the following conditions: Chronic Rejection.

Who is sponsoring clinical trial NCT00283348?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00283348 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03476681 · 121 participants · Phase 1

    Study of NEO-201 in Solid Tumors Expansion Cohorts

  • NCT04655118 · 121 participants · Phase 2

    Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

  • NCT04676802 · 121 participants · Phase 2

    Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

  • NCT05169515 · 121 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00283348, the US trial registry maintained by the National Library of Medicine. NCT00283348 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.